Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Psychopharmacology|October 6, 2021
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studiesDimitri Daldegan-Bueno, Lucas O Maia, Michelle Glass, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2021
Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studiesDimitri Daldegan-Bueno, Lucas O Maia, Michelle Glass, et al.
British Journal of Pharmacology|January 18, 2006
Differential activation of G-proteins by mu-opioid receptor agonistsZuzana Saidak, Katherine Blake-Palmer, Debbie L Hay, et al.
Molecular Genetics and Genomics : MGG|January 27, 2007
A shifted repertoire of endocannabinoid genes in the zebrafish (Danio rerio)J M McPartland, Michelle Glass, Isabel Matias, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary LeukocytesYurii Saroz, Dan T Kho, Michelle Glass, et al.
ACS Chemical Neuroscience|January 29, 2019
Dark Classics in Chemical Neuroscience: Δ9-TetrahydrocannabinolSamuel D Banister, Jonathon C Arnold, Mark Connor, et al.
Journal of Chemical Neuroanatomy|July 1, 2014
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brainMegan J Dowie, Natasha L Grimsey, Therri Hoffman, et al.
Cellular and Molecular Life Sciences : CMLS|November 22, 2025
Insights into cannabinoid receptor 2 (CB2) anterograde trafficking and pharmacological chaperoningCaitlin R M Oyagawa, Braden Woodhouse, Karren C Wood, et al.
Molecular Pharmacology|June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid ReceptorElham Khajehali, Daniel T Malone, Michelle Glass, et al.
The Journal of Biological Chemistry|July 26, 2006
Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathwayE Scott Graham, Nicola Ball, Emma L Scotter, et al.
Pageof 14